RxDoctor Payments Data

Michael Shipman, PA

Physician Assistant · Lancaster, PANPI 1437159951

Payments from drug & device makers

$12,300in general payments, 2019–2025

Across 768 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$954
  • Pfizer$854
  • GSK$600
  • plus $5K from 35 others

What the payments were for

  • Food & beverage$12,300100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,300 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$16,359
Medicare patients
121
Services billed
250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide45$59,834
EliquisApixaban50$37,130
JanuviaSitagliptin Phosphate22$29,984
OzempicSemaglutide28$25,895
JardianceEmpagliflozin34$24,507
FarxigaDapagliflozin Propanediol22$20,092
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,390
XareltoRivaroxaban17$13,072
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$11,602
Combivent RespimatIpratropium/Albuterol Sulfate13$6,000
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$5,840
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$5,499
VascepaIcosapent Ethyl11$3,860
Atorvastatin Calcium313$3,117
Albuterol Sulfate HfaAlbuterol Sulfate83$3,108

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$954$59,83445 claims
PfizerEliquis$854$37,13050 claims
Boehringer IngelheimJardiance, Combivent Respimat$586$30,50747 claims
MerckJanuvia$404$29,98422 claims
Novo NordiskOzempic$1,415$25,89528 claims
AstraZenecaFarxiga$1,640$20,09222 claims
GSKTrelegy Ellipta$600$13,39013 claims
Johnson & JohnsonXarelto$241$13,07217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →